Highly Selective Artificial K+ Transporters Reverse Liver Fibrosis In Vivo

Highly Selective Artificial K+ Transporters Reverse Liver Fibrosis In Vivo

Saved in:

Bibliographic Details
Main Authors:	Qiuping Zhang, Qinghong Liang, Guijiang Wang, Xiaopan Xie, Yin Cao, Nan Sheng, Zhiping Zeng, Changliang Ren
Format:	Article
Language:	English
Published:	American Chemical Society 2024-08-01
Series:	JACS Au
Online Access:	https://doi.org/10.1021/jacsau.4c00521
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Artificial Tyroserleutide Transporters for Synergistic Cancer Therapy
by: Daoxin Luo, et al.
Published: (2025-05-01)

Ultrasound artificial intelligence in the assessment of liver fibrosis
by: HUANG Xiulin, CHEN Chengcai, LUO Tingting, LU Jiao, LIU Anxin, FENG Shiwen
Published: (2025-05-01)

Quantification Accuracy of Liver Fibrosis by In Vivo Elastography and Digital Image Analysis of Liver Biopsy Histochemistry
by: Justinas Besusparis, et al.
Published: (2014-01-01)

The Novel Long-Acting Peptide S6-FA Attenuates Liver Fibrosis In Vitro and In Vivo
by: Mingmin Li, et al.
Published: (2025-02-01)

New Surgical Technique to Induce Reversible Liver Fibrosis by Surgical Closure of Major Duodenal Orifice in Dogs
by: Marwan Khalil, et al.
Published: (2021-12-01)

The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice.
by: Ivan Tancevski, et al.
Published: (2010-01-01)

Ex Vivo and in Vivo Administration of Fluorescent CNA35 Specifically Marks Cardiac Fibrosis
by: Sanne de Jong, et al.
Published: (2014-12-01)

Application of mesenchymal stem cells in liver fibrosis and regeneration
by: Zhenyu Liu, et al.
Published: (2024-12-01)

Mathematical modeling of liver fibrosis
by: Avner Friedman, et al.
Published: (2017-01-01)

The Effects of Curcumin on NF-κB Level and Degree of Liver Fibrosis in Rat Liver Fibrosis
by: Supriono, et al.
Published: (2018-12-01)

Quantitative ultrasound rating of liver fibrosis in children with cystic fibrosis
by: G. M. Dvoryakovskaya, et al.
Published: (2014-08-01)

Posterior reversible encephalopathy syndrome in adult acute post-streptococcal glomerulonephritis
by: Qiuping Han, et al.
Published: (2025-02-01)

CT-based artificial intelligence system complementing deep learning model and radiologist for liver fibrosis staging
by: Shuang Zheng, et al.
Published: (2025-04-01)

Sphingosine Kinase 1 – A Therapeutic Opportunity for Alleviating Liver Fibrosis?
by: Jia Ming Nickolas Teo, et al.
Published: (2025-01-01)

Electrically-driven reversible phonon transport manipulation in two-dimensional heterostructures
by: Yufei Sheng, et al.
Published: (2025-02-01)

Study on Characteristics of 4.5 kV Reverse Blocking IGCT for HVDC
by: Xuejun PAN, et al.
Published: (2021-09-01)

Pirfenidone combined with UC-MSCs reversed bleomycin-induced pulmonary fibrosis
by: Jingran Xu, et al.
Published: (2025-08-01)

Inhibition of Talin2 dedifferentiates myofibroblasts and reverses lung and kidney fibrosis
by: Michael J. V. White, et al.
Published: (2025-05-01)

Challenges of in vitro modelling of liver fibrosis
by: Patricia Ros-Tarraga, et al.
Published: (2025-04-01)

Mechanisms of liver fibrosis in metabolic syndrome
by: Wajahat Mehal
Published: (2023-08-01)

MODERN METHODS FOR ESTIMATION OF LIVER FIBROSIS
by: E. V. Guschina, et al.
Published: (2015-08-01)

Immune Checkpoints and the Immunology of Liver Fibrosis
by: Ioannis Tsomidis, et al.
Published: (2025-01-01)

Defenestration of Liver Sinusoidal Endothelial Cells: The Trigger of Liver Fibrosis
by: Juntao Zhou, et al.
Published: (2025-06-01)

Hepatic ferroptosis induced by Clonorchis sinensis exacerbates liver fibrosis.
by: Haoyang Zhang, et al.
Published: (2025-06-01)

Nanowire‐Based Flexible Sensors for Wearable Electronics, Brain–Computer Interfaces, and Artificial Skins
by: Xiaopan Song, et al.
Published: (2025-05-01)

Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis
by: Sabina Więcek, et al.
Published: (2020-01-01)

aHSCs-targeted bimetallic nanozymes and luteolin-loaded liposomes: Synergistic reversal of liver fibrosis via antioxidant, cellular senescence, and cellular apoptotic mechanisms
by: Zihao Sun, et al.
Published: (2025-10-01)

Author Correction: Targeting pleuro-alveolar junctions reverses lung fibrosis in mice
by: Adrian Fischer, et al.
Published: (2025-02-01)

Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
by: Yuri Cho
Published: (2024-11-01)

Normalization of Cystic Fibrosis Immune System Reverses Intestinal Neutrophilic Inflammation and Significantly Improves the Survival of Cystic Fibrosis MiceSummary
by: Callie E. Scull, et al.
Published: (2025-01-01)

Proportion and clinical characteristics of metabolic-associated fatty liver disease and associated liver fibrosis in an urban Chinese population
by: Mengmeng Hou, et al.
Published: (2025-04-01)

Nephrogenic Systemic Fibrosis Risk and Liver Disease
by: Robert F. Hanna, et al.
Published: (2014-01-01)

Current strategies for targeted therapy of liver fibrosis
by: D. V. Garbuzenko
Published: (2022-10-01)

Modern concepts on pathogenetic mechanisms of liver fibrosis
by: N. A. Efremova, et al.
Published: (2023-04-01)

Mechanisms and Biomarkers of Apoptosis in Liver Disease and Fibrosis
by: Jayashree Bagchi Chakraborty, et al.
Published: (2012-01-01)

Nanomedicines in the Treatment of Liver Fibrosis: A Review
by: Du X, et al.
Published: (2025-08-01)

Apolipoprotein L2's Role in Liver Fibrosis
by: Etienne Pays
Published: (2025-01-01)

Integrated neural network and evolutionary algorithm approach for liver fibrosis staging: Can artificial intelligence reduce patient costs?
by: Ali Nazarizadeh, et al.
Published: (2024-05-01)

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
by: Mark Terence P. Mujer, et al.
Published: (2020-01-01)

Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
by: Maria Sara Remedi, et al.
Published: (2008-10-01)